Physician profile
Allison Cherry
NPI 1871599399
$1,960.07
in general payments reported to CMS, 2019-2025
22 companies · $14.22 in 2025
The $14.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $515 · 2021: $450 · 2022: $432 · 2023: $51.60 · 2024: $15.43 · 2025: $14.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $388.20 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $345.12 | 2019-2023 | Livalo, Seglentis |
| Abbott Laboratories | $215.79 | 2021-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $194.85 | 2019-2022 | |
| Lilly USA, LLC | $176.61 | 2019-2023 | Mounjaro, Trulicity |
| Bayer Healthcare Pharmaceuticals INC. | $83.64 | 2022 | |
| Amgen INC. | $83.00 | 2020-2022 | |
| Mylan Specialty L.P. | $79.90 | 2019-2022 | |
| Novo Nordisk INC | $57.83 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $53.12 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.04 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $49.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $38.13 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $31.32 | 2019-2022 | |
| Bardy Diagnostics, INC. | $15.02 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.89 | 2021 | |
| Cipher Pharmaceuticals US LLC | $14.22 | 2025 | Spinosad, Natroba |
| Astellas Pharma US INC | $14.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.56 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.90 | 2020 | |
| Amarin Pharma, INC. | $12.61 | 2020 | |
| Horizon Therapeutics Plc | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Cherry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.